EUVIMEDEUVIMED entdecken
Crossref

Saxagliptin a New Second Line Therapy After Metformin for the Treatment of Type 2 Diabetes

Clinical Medicine Reviews in Vascular Health · 2010

DOI: 10.4137/cmrvh.s4535 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Medicine Reviews in Vascular Health, 2010.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2010). Saxagliptin a New Second Line Therapy After Metformin for the Treatment of Type 2 Diabetes. Clinical Medicine Reviews in Vascular Health. https://doi.org/10.4137/cmrvh.s4535

Vancouver

Saxagliptin a New Second Line Therapy After Metformin for the Treatment of Type 2 Diabetes. Clinical Medicine Reviews in Vascular Health. 2010. doi:10.4137/cmrvh.s4535

BibTeX
@article{euvimed2010,
  title = {Saxagliptin a New Second Line Therapy After Metformin for the Treatment of Type 2 Diabetes},
  journal = {Clinical Medicine Reviews in Vascular Health},
  year = {2010},
  doi = {10.4137/cmrvh.s4535}
}
Kostenlos starten →